实用肝脏病杂志 ›› 2023, Vol. 26 ›› Issue (4): 560-563.doi: 10.3969/j.issn.1672-5069.2023.04.027

• 肝移植 • 上一篇    下一篇

接受亲体左外叶活体肝移植小儿术后肝功能和肝脏血流参数变化*

雷国龙, 杨琦, 唐奇, 陈敏   

  1. 410000 长沙市第一医院超声科(雷国龙,唐奇);南华大学附属长沙中心医院儿科(杨琦);湖南师范大学附属第一医院/湖南省人民医院超声科(陈敏)
  • 收稿日期:2023-05-05 出版日期:2023-07-10 发布日期:2023-07-21
  • 通讯作者: 杨琦,E-mail:1066951607@qq.com
  • 作者简介:雷国龙,男,35岁,硕士研究生,主治医师。研究方向:主要从事超声诊断研究。E-mail:leiguolongcs@163.com
  • 基金资助:
    *湖南省长沙市科技局科研项目(编号:kzd21086)

Liver function test and hepatic blood flow parameter changes in children with benign liver diseases after living donor liver transplantation

Lei Guolong, Yang Qi, Tang Qi, et al   

  1. Department of Ultrasound, First Hospital, Changsha 410000, Hunan Province, China
  • Received:2023-05-05 Online:2023-07-10 Published:2023-07-21

摘要: 目的 研究接受活体肝移植(LDLT)术治疗的小儿术后肝功能指标和肝脏血流参数的变化。 方法 2019年4月~2022年4月我院诊治的47例良性肝病患者,均接受亲体左外叶LDLT术治疗,使用超声检测门静脉血流量(PFV)、门静脉血流指数(PFI)、肝动脉血流量(HFV)和肝动脉血流指数(HFI)。 结果 术前,本组患儿血清TBIL、ALB、INR和ALT水平分别为(226.3±35.8)μmol/L、(32.9±6.1)g/L、(1.2±0.2)和(79.8±25.1)U/L,术后1 d 分别为(126.3±29.5)μmol/L、(30.1±5.3)g/L、(1.4±0.3)和(427.5±112.6)U/L,以后各指标逐渐恢复正常;术前,本组小儿HFV、HFI、PFV和PFI分别为(81.6±12.5)ml/min、(31.2±10.5)ml/min.100 g、(568.9±126.8)ml/min和(315.6±96.5)ml/min.100 g,术后1 d分别为(134.7±52.8)ml/min、(58.8±24.2)ml/min.100 g、(1128.3±572.6)ml/min和(552.7±242.4)ml/min.100 g,而后各指标逐渐恢复正常;在术后13 d和15 d,2例患儿发生急性肝功能衰竭,死亡;在接受LDLT术后30 d,45例患儿肝功能指标顺利恢复;在随访期间生存患儿未发生明确的血管并发症。 结论 接受左外叶LDLT术治疗患儿术后肝功能指标以及超声检测的肝动脉和门静脉血管参数会发生一些规律性变化,对判断移植肝成活有帮助,应注意临床监测。

关键词: 胆道锁闭, 肝糖原沉积病, 活体肝移植术, 肝功能, 肝脏血流参数, 儿童

Abstract: Objective The aim of this study was to investigate the liver function test and hepatic blood flow parameter changes in children with benign liver diseases after living donor liver transplantation (LDLT). Methods 47 patients with benign liver diseases including congenital biliary atresia in 36 cases and glycogenosis in 11 cases, were encountered in our hospital between April 2019 and April 2022, and all underwent left-leaf LDLT. Serum total bilirubin (TBIL), albumin (ALB), international normalized ratio (INR) of prothrombin time and alanine transaminase (ALT) levels were detected routinely. The portal flow volume (PFV), portal flow index (PFI), hepatic flow volume (HFV) and hepatic flow volume index (HFI) were measured by ultrasonography. Results At presentation, serum TBIL, ALB, INR and ALT levels in our series were (226.3±35.8)μmol/L, (32.9±6.1)g/L, (1.2±0.2) and (79.8±25.1)U/L, one day after operation, they changed to (126.3±29.5)μmol/L, (30.1±5.3)g/L, (1.4±0.3) and (427.5±112.6)U/L, and they gradually returned to normal; at admission, the HFV, HFI, PFV and PFI in our series were (81.6±12.5)ml/min, (31.2±10.5) ml/min.100 g, (568.9±126.8)ml/min and (315.6±96.5)ml/min.100 g, one day after surgery, they changed to (134.7±52.8)ml/min, (58.8±24.2)ml/min.100 g, (1128.3±572.6)ml/min and (552.7±242.4)ml/min.100 g, and thereafter, they gradually returned to normal; 13 days and 15 days after operation, two children died of acute liver failure; one month after LDLT, 45 children recovered with normal liver function tests; during the follow-up period, no untoward complications of hepatic vessels was found in the survivals. Conclusion The liver function tests and hepatic vascular parameters could changes regularly, which might help judge the states of transplants, and should carefully surveyed.

Key words: Congenital biliary atresia, Glycogenosis, Living donor liver transplantation, Hepatic flow parameters, Children